Agilent customers are finding new ways to treat cancer, ensure food, water, air, and medicine quality and safety, discover new drug treatments, research infectious diseases, and create alternative energy solutions for a greener planet. From start to finish, we have them covered with our vast product solutions and services portfolio.
Around the world, Agilent’s people bring innovations, technologies, and services to the forefront of science. Our teams design and manufacture a wide array of advanced analytical, research, and diagnostic solutions and tools for use inside and outside laboratories.
Additionally, the unique expertise of Agilent’s CrossLab and technical teams provides valuable insight and support to our customers, helping them fully optimize their laboratories and resources to better focus on what's important: bringing great science to life.
In fiscal 2022, Agilent Technologies generated revenue of (US) $6.85 billion.
-
Industry
-
Biotechnology Research
-
Company size
-
10,001+ employees
-
Headquarters
-
Singapore
-
Founded
-
1999
-
Specialties
-
Academia, Biopharma/Pharma, Cancer Research, Cannabis & Hemp Testing, Cell Analysis, Clinical Diagnostics, Clinical Research, Companion Diagnostics, Energy and Chemicals, Environmental, Food and Beverage Testing, Forensics, Genomics, Infectious Diseases, Materials Testing & Research, Omics, Pathology, and Vacuum Solutions
